Public

NEW YORK and VIENNA, Austria, May 31, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (Nasdaq: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the…

WALTHAM, Mass., May 26, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the…

FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Phathom…

PHILADELPHIA, May 22, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio,…

PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) -- Agile…

Oak Ridge, TN, May 19, 2023 (GLOBE NEWSWIRE) -- DAXOR…

WILMINGTON, Del., May 17, 2023 (GLOBE NEWSWIRE) -- Prelude…

PALO ALTO, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Intapp,…

PHILADELPHIA, May 17, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio,…

PALO ALTO, Calif., May 16, 2023 (GLOBE NEWSWIRE) -- Intapp,…